Urinary Fumaric Acid (Fumarate)
Trans-dicarboxylic acid intermediate formed by SDH oxidation of succinate and hydrated into malate via fumarate hydratase (FH).
Standard vs. Optimal Reference Rangesug/mg Cr
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
0.2 - 2.5 ug/mg Cr
General reference distribution across unselected commercial populations.
0.5 - 1.8 ug/mg Cr
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Inborn deficiency or FH inhibition accumulates fumarate, which succinates cysteine residues on KEAP1, activating the Nrf2 antioxidant defense.
Differential Diagnosis
Elevated Levels (Fumarate High)
- •Fumarase / Fumarate Hydratase deficiency
- •Severe mitochondrial respiratory chain block
Low Levels (Fumarate Low)
- •Normal hydration into malate
- •Quiescent mitochondrial turnover
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Fumarate
- Targeted organ system imaging or functional dynamic testing related to fumarate hydratase & nrf2 activation
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Urinary Fumaric Acid - The New England Journal of Medicine (2021). PMID: 34190124
- [2]Fumarate Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Urinary Fumaric Acid (Fumarate) into overall healthspan optimization.